- Home
- BCML vs FDMT Comparison
BCML vs FDMT Comparison
Compare BCML & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCML
- FDMT
- Stock Information
- Founded
- BCML 2004
- FDMT 2013
- Country
- BCML United States
- FDMT United States
- Employees
- BCML N/A
- FDMT N/A
- Industry
- BCML Major Banks
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- BCML Finance
- FDMT Health Care
- Exchange
- BCML Nasdaq
- FDMT Nasdaq
- Market Cap
- BCML 294.2M
- FDMT 192.2M
- IPO Year
- BCML N/A
- FDMT 2020
- Fundamental
- Price
- BCML $27.93
- FDMT $4.35
- Analyst Decision
- BCML
- FDMT Buy
- Analyst Count
- BCML 0
- FDMT 10
- Target Price
- BCML N/A
- FDMT $32.33
- AVG Volume (30 Days)
- BCML 31.1K
- FDMT 418.9K
- Earning Date
- BCML 07-21-2025
- FDMT 08-07-2025
- Dividend Yield
- BCML 2.84%
- FDMT N/A
- EPS Growth
- BCML N/A
- FDMT N/A
- EPS
- BCML 2.10
- FDMT N/A
- Revenue
- BCML $95,714,000.00
- FDMT $23,000.00
- Revenue This Year
- BCML $1.24
- FDMT $13,048.65
- Revenue Next Year
- BCML $6.52
- FDMT N/A
- P/E Ratio
- BCML $13.40
- FDMT N/A
- Revenue Growth
- BCML N/A
- FDMT N/A
- 52 Week Low
- BCML $20.23
- FDMT $2.24
- 52 Week High
- BCML $30.13
- FDMT $28.93
- Technical
- Relative Strength Index (RSI)
- BCML 54.53
- FDMT 55.44
- Support Level
- BCML $27.40
- FDMT $4.23
- Resistance Level
- BCML $29.46
- FDMT $4.50
- Average True Range (ATR)
- BCML 0.81
- FDMT 0.26
- MACD
- BCML 0.06
- FDMT 0.01
- Stochastic Oscillator
- BCML 53.36
- FDMT 78.05
About BCML BayCom Corp
BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.